Edition:
United States

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

6.15USD
20 Jul 2018
Change (% chg)

$0.05 (+0.82%)
Prev Close
$6.10
Open
$6.10
Day's High
$6.25
Day's Low
$6.10
Volume
99,186
Avg. Vol
66,135
52-wk High
$13.15
52-wk Low
$5.80

Chart for

About

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to... (more)

Overall

Beta: --
Market Cap(Mil.): $176.88
Shares Outstanding(Mil.): 29.00
Dividend: --
Yield (%): --

Financials

  NEOS.OQ Industry Sector
P/E (TTM): -- 29.12 33.34
EPS (TTM): -2.40 -- --
ROI: -97.68 13.60 13.18
ROE: -1,571.92 15.30 15.09

BRIEF-Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities

* NEOS THERAPEUTICS REITERATES CONFIDENCE IN STRATEGIC PLAN AND VALUE CREATION OPPORTUNITIES

Feb 20 2018

BRIEF-Jack Schuler Reports 8.1 Pct Passive Stake In Neos Therapeutics

* JACK SCHULER REPORTS 8.1 PERCENT PASSIVE STAKE IN NEOS THERAPEUTICS INC AS ON DECEMBER 31, 2017 - SEC FILING Source text: (http://bit.ly/2nOrQlw) Further company coverage:

Feb 08 2018

Competitors

  Price Chg
Eli Lilly And Co (LLY.N) $88.47 -0.96
Pfizer Inc. (PFE.N) $37.33 -0.03
Concordia International Corp (CXR.TO) $0.26 +0.00
Novartis AG (NOVN.S) CHF82.20 +1.24
Shire PLC (SHP.L) 4,382.50 -62.00
Shire PLC (3159084.L) -- --

Earnings vs. Estimates